Bio-Rad Laboratories (BIO) Other Non-Current Assets (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Other Non-Current Assets of $102.8 million for Q1 2026, down 0.87% year-over-year from $103.7 million in Q1 2025, and little changed quarter-over-quarter from $102.7 million in Q4 2025.
Bio-Rad Laboratories (BIO) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 18 years of Other Non-Current Assets data on file, last reported at $102.8 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $102.8 million, down 0.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.8 million (down 0.87% YoY), and the FY2025 annual result was $102.7 million, up 0.79% from the prior year.
- Other Non-Current Assets was little changed at $102.8 million in Q1 2026 per BIO's latest filing, from $102.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $109.0 million in Q3 2025 and troughed at $92.9 million in Q1 2024.
- A 5-year average of $100.8 million and a median of $101.8 million in 2022 frame the typical range for Other Non-Current Assets.
- On a YoY basis, Other Non-Current Assets climbed as much as 12.73% in 2022 and fell as far as 9.2% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $94.6 million in 2022, then increased by 0.32% to $94.9 million in 2023, then rose by 7.38% to $101.9 million in 2024, then climbed by 0.79% to $102.7 million in 2025, then climbed by 0.1% to $102.8 million in 2026.
- Business Quant data shows BIO's Other Non-Current Assets at $102.8 million in Q1 2026, $102.7 million in Q4 2025, and $109.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Bio-Rad Laboratories | 7.62 Bn | 6.05 Bn | 309.40 Mn | 102.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.80 Mn |
| Dec 31, 2025 | 102.70 Mn |
| Sep 30, 2025 | 109.00 Mn |
| Jun 30, 2025 | 107.90 Mn |
| Mar 31, 2025 | 103.70 Mn |
| Dec 31, 2024 | 101.90 Mn |
| Sep 30, 2024 | 103.62 Mn |
| Jun 30, 2024 | 98.19 Mn |
| Mar 31, 2024 | 92.87 Mn |
| Dec 31, 2023 | 94.90 Mn |
| Sep 30, 2023 | 98.47 Mn |
| Jun 30, 2023 | 100.06 Mn |
| Mar 31, 2023 | 95.51 Mn |
| Dec 31, 2022 | 94.60 Mn |
| Sep 30, 2022 | 101.77 Mn |
| Jun 30, 2022 | 100.89 Mn |
| Mar 31, 2022 | 103.93 Mn |
| Dec 31, 2021 | 104.19 Mn |
| Sep 30, 2021 | 106.63 Mn |
| Jun 30, 2021 | 99.07 Mn |